200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 5623-95-0
5623-95-0 | Piperazine-1-carboxamide
CAS No: 5623-95-0 Catalog No: AG003TSQ MDL No:MFCD00015904
Product Description
Catalog Number:
AG003TSQ
Chemical Name:
Piperazine-1-carboxamide
CAS Number:
5623-95-0
Molecular Formula:
C5H11N3O
Molecular Weight:
129.1603
MDL Number:
MFCD00015904
IUPAC Name:
piperazine-1-carboxamide
InChI:
InChI=1S/C5H11N3O/c6-5(9)8-3-1-7-2-4-8/h7H,1-4H2,(H2,6,9)
InChI Key:
IVXQBCUBSIPQGU-UHFFFAOYSA-N
SMILES:
NC(=O)N1CCNCC1
NSC Number:
86952
Properties
Complexity:
109
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
129.09g/mol
Formal Charge:
0
Heavy Atom Count:
9
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
129.163g/mol
Monoisotopic Mass:
129.09g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
58.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.5
Literature
| Title | Journal |
|---|---|
| Confirming target engagement for reversible inhibitors in vivo by kinetically tuned activity-based probes. | Journal of the American Chemical Society 20120627 |
| Design, synthesis, and structure-activity relationships of indole-3-heterocycles as agonists of the CB1 receptor. | Bioorganic & medicinal chemistry letters 20110101 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain. | Molecular pain 20100101 |
| Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors. | Bioorganic & medicinal chemistry letters 20090615 |
| Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates. | Purinergic signalling 20090301 |
| Selective P2X(7) receptor antagonists for chronic inflammation and pain. | Purinergic signalling 20090301 |
| 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor. | Bioorganic & medicinal chemistry 20080315 |
| Synthesis and evaluation of a small library of graftable thrombin inhibitors derived from (L)-arginine. | European journal of medicinal chemistry 20070101 |
| Photoinduced chemiluminescence of pharmaceuticals. | Journal of pharmaceutical and biomedical analysis 20060503 |
| Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects. | The Journal of pharmacology and experimental therapeutics 20030601 |
| Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs. | Bioorganic & medicinal chemistry letters 20020805 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.